SAB Biotherapeutics, Inc. (SABS) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$3.52
+1.30%
Mkt Cap $33.17M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 9, 2026 | $100.00K | — | — | -$0.16 | -$0.46 | -187.50% | — | — |
| Q4 2025 Nov 14, 2025 | $100.00K | — | — | -$0.59 | -$0.21 | +64.41% | — | — |
| Q3 2025 Aug 7, 2025 | $83.33K | — | — | -$0.82 | -$1.09 | -32.93% | — | — |
| Q2 2025 May 9, 2025 | $125.00K | — | — | -$1.00 | -$0.56 | +44.00% | — | — |
| Q1 2025 Mar 28, 2025 | $120.00K | $100.00K | -16.67% | -$1.16 | -$1.23 | -6.03% | — | — |
| Q4 2024 Nov 6, 2024 | $150.00K | -$410 | -100.27% | -$1.07 | -$1.12 | -4.67% | — | — |
| Q3 2024 Aug 8, 2024 | — | $263.14K | — | -$1.13 | -$0.79 | +30.09% | — | — |
| Q2 2024 May 20, 2024 | — | $944.58K | — | -$0.98 | -$0.54 | +44.90% | — | — |
| Q2 2024 Apr 1, 2024 | — | $305.01K | — | -$0.62 | -$3.38 | -445.16% | — | — |
| Q4 2023 Nov 13, 2023 | $11.97K | $1.27M | +10488.33% | -$1.00 | -$1.00 | +0.00% | — | — |
| Q3 2023 Aug 21, 2023 | $410.00K | $85.52K | -79.14% | -$1.60 | -$1.40 | +12.50% | — | — |
| Q2 2023 May 16, 2023 | $2.54M | $600.00K | -76.38% | -$0.80 | -$1.50 | -87.50% | — | — |
| Q2 2023 Apr 14, 2023 | $6.50M | $2.16M | -66.75% | -$0.04 | -$1.56 | -3807.03% | — | — |
| Q4 2022 Nov 15, 2022 | $5.90M | $3.59M | -39.18% | -$1.40 | -$1.60 | -14.29% | — | — |
| Q3 2022 Aug 10, 2022 | $10.80M | $6.35M | -41.19% | -$1.30 | -$1.10 | +15.38% | — | — |
| Q2 2022 May 12, 2022 | $11.47M | $11.80M | +2.93% | -$1.20 | -$1.50 | -25.00% | — | — |
| Q1 2022 Mar 29, 2022 | $60.88M | $60.88M | +0.00% | -$0.11 | -$0.66 | -500.00% | — | — |
| Q4 2021 Nov 22, 2021 | $16.90M | $14.70M | -13.00% | -$0.09 | -$0.02 | +77.78% | — | — |
| Q3 2021 Aug 9, 2021 | — | — | — | — | -$0.68 | — | — | — |
| Q2 2021 May 21, 2021 | — | — | — | — | $0.32 | — | — | — |
| Q2 2021 Apr 2, 2021 | — | — | — | — | -$0.01 | — | — | — |